Bernstein Maintains Outperform on Intuitive Surgical, Lowers Price Target to $685

Benzinga Newsdesk www.benzinga.com Negative 94.2%

Neg 94.2% Neu 0% Pos 0%

Bernstein analyst Lee Hambright maintains Intuitive Surgical (NASDAQ:ISRG) with a Outperform and lowers the price target from $750 to $685.